Wednesday 2 June 2021


Dr Sarah Gilbert, Dr Bruce Walker, Dr Timothy Ferris, in collaboration with Mass General, MIT and Harvard

Doctors at the forefront of vaccine development

COVID-19 Vaccine Development

In a conversation moderated by Dr Timothy Ferris, Dr Bruce Walker and Dr Sarah Gilbert, will be relating how swift vaccine development and deployment came to be, and how the successes and challenges faced in global vaccination efforts will influence scientific and pandemic response around the world as we move forward.

Dr Sarah Gilbert

Sarah is Professor of Vaccinology at Oxford University and co-founder of Vaccitech.

She specialises in the development of vaccines against influenza and emerging viral pathogens and led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011. On 30 December 2020, the Oxford–AstraZeneca COVID-19 vaccine she co-developed with the Oxford Vaccine Group was approved for use in the Unit and has since been rolled out across the world.

Dr Bruce Walker

Bruce is the founding Director of the Ragon Institute of MGH, MIT, and Harvard, a Professor of Medicine at Harvard Medical School, Professor of Practice at MIT, and a Howard Hughes Medical Institute (HHMI) Investigator. In addition to his clinical duties as a board certified Infectious Disease specialist, his research focuses on cellular immune responses in chronic human viral infections, with a particular focus on HIV immunology and vaccine development.

Dr Timothy Ferris

Tim joins the NHS in May to lead the organisation’s new Transformation Directorate, bringing together the NHSE/I operational improvement team and NHSX. It aims to maintain the pace of innovation seen during the Covid-19 pandemic.

He was previously CEO of the Mass General Physicians Organization and prior to Mass Gen, Tim was the senior VP for population health at Partners HealthCare.